Trial Profile
Clinical Trials Insight: 700033183
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 May 2008
Price :
$35
*
At a glance
- Drugs AMG 222 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Amgen
- 05 May 2008 New trial record.
- 25 Apr 2008 Results are expected in late 2008 or early 2009.